期刊
NATURE
卷 491, 期 7424, 页码 364-373出版社
NATURE PUBLISHING GROUP
DOI: 10.1038/nature11706
关键词
-
资金
- Cancer Research UK
- EMBO
- Oxford Cancer Imaging Centre
- Breast Cancer Research Foundation
- Oxford NIHR Biomedical Research Centre
- Cancer Research UK [11359] Funding Source: researchfish
- National Institute for Health Research [NF-SI-0611-10163] Funding Source: researchfish
Cancer metabolism has received a substantial amount of interest over the past decade. The advances in analytical tools have, along with the rapid progress of cancer genomics, generated an increasingly complex understanding of metabolic reprogramming in cancer. As numerous connections between oncogenic signalling pathways and metabolic activities emerge, the importance of metabolic reprogramming in cancer is being increasingly recognized. The identification of metabolic weaknesses of cancer cells has been used to create strategies for treating cancer, but there are still challenges to be faced in bringing the drugs that target cancer metabolism to the clinic.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据